February 2024 Ozempic Update On February 2, 2024, the Judicial Panel on Multidistrict Litigation ordered that all Ozempic, and other GLP-1 medication cases, be consolidated in the United States District Court for the Eastern District of Pennsylvania
Micronutrient fortification of food and its impact on woman and child health: a systematic review
TMates' terms and disclosures describe the company as a technology platform and state it does not provide medical advice, diagnosis, or treatment
However: Success requires moving beyond generic advice like eat less and move more. Effective digital companions must target the root causes of obesity and address the specific challenges patients face during treatment
Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance
Wegovy $9 if insured, vs $514 / pound lost if paying retail